CT1812 biomarker signature from a meta‐analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease
Lizama B, Williams C, North H, Pandey K, Duong D, Di V, Mecca A, Blennow K, Zetterberg H, Levey A, Grundman M, van Dyck C, Caggiano A, Seyfried N, Hamby M. CT1812 biomarker signature from a meta‐analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease. Alzheimer's & Dementia 2024, 20: 6860-6880. PMID: 39166791, PMCID: PMC11485314, DOI: 10.1002/alz.14152.Peer-Reviewed Original ResearchVolumetric magnetic resonance imagingMagnetic resonance imagingPharmacodynamic biomarkersMeta-analysisClinical developmentCerebrospinal fluidPhase 2 clinical trialResonance imagingAlzheimer's diseaseMechanism of actionClinical trialsTandem mass tag-mass spectrometryClinical cohortMild to moderate ADCandidate biomarkersCT1812CohortBiomarker signaturesBiomarkersProteomic findingsUnbiased analysisNetwork analysisAmyloid-betaSynaptic biologyBiological impactNative-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer’s pathology
Kumar P, Goettemoeller A, Espinosa-Garcia C, Tobin B, Tfaily A, Nelson R, Natu A, Dammer E, Santiago J, Malepati S, Cheng L, Xiao H, Duong D, Seyfried N, Wood L, Rowan M, Rangaraju S. Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer’s pathology. Nature Communications 2024, 15: 2823. PMID: 38561349, PMCID: PMC10985119, DOI: 10.1038/s41467-024-47028-7.Peer-Reviewed Original ResearchConceptsBiotinylation of proteinsAlzheimer's diseasePre-synaptic defectsDecreased mTOR signalingAD pathogenesisAD riskCytoskeletal disruptionProteomic alterationsTranslational activityMolecular insightsMTOR signalingProteomic findingsProteomicsProteomic signatureMolecular signaturesProteinOver-representedProgressive neuropathologyAlzheimer pathologyMouse modelPV-INsParvalbumin interneuronsMitochondriaAssociated with cognitive declineFast-spiking parvalbumin interneurons
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply